Game Changer: Merck's Stealth Keytruda-Chemo Filing Stirs NSCLC Market Dynamics

 
• By Lucie Ellis-Taitt
Sparrow
Early bird Merck hopes to catch the worm, files Keytruda/Chemo combo months sooner than expected • Source: Shutterstock

More from Immuno-oncology

More from Anticancer